More Articles

Also noted on generics: 22 March 2012 Generics/General | Posted 23/03/2012

Watson confirms patent challengesWatson Pharmaceuticals (Watson) confirmed that lawsuits had been filed against the generics company regarding two Abbreviated New Drug Applications it had submitte...

Pfizer and Biocon’s biosimilar insulin deal is off Biosimilars/News | Posted 16/03/2012

Pfizer, the world’s largest pharma company, and Indian biosimilars major Biocon announced on 12 March 2012 that they had decided to end their biosimilar insulin deal due to ‘differing priorities’.

Canada’s generics and brand-name pharma come together to tackle drug shortages Pharma News | Posted 16/03/2012

Canada’s Research-Based Pharmaceutical Companies (Rx&D) and the Canadian Generic Pharmaceutical Association (CGPA) announced on 12 March 2012 their commitment and financial support in respondin...

Cost savings due to prescribing of generic PPIs and statins in Scotland Generics/Research | Posted 16/03/2012

Significant cost savings can be made by governments by encouraging prescribing of generics rather than brand-name drugs. In Scotland, in an effort to control medicines expenditure, measures were in...

AARP report highlights importance of generics Reports | Posted 16/03/2012

According to a report issued on 6 March 2012 by AARP (formerly the American Association of Retired Persons) the prices of drugs used most widely by older Americans rose by nearly 26% from 2005 to 2...

Generics reach 80% and play a critical role in reducing costs Generics/General | Posted 16/03/2012

Prescription drug spending in the US reached US$307 billion in 2010–an increase of US$135 billion since 2001–and comprised approximately 12% of all healthcare spending in the country, according to...

First generic atorvastatin launched in Australia and Europe Generics/News | Posted 16/03/2012

On 6 March 2012, Ranbaxy announced that it had obtained, pursuant to a settlement agreement with Pfizer, the rights to an early entry of its generic atorvastatin in Germany, Italy, The Netherlands...

Indian Government issues first compulsory licence Generics/General | Posted 16/03/2012

The Indian Government has issued a compulsory licence for the first time, allowing India-based drugmaker Natco Pharma (Natco) to launch a generic version of Bayer’s liver and kidney cancer drug Nex...